Year/Sem.: I / I THEORY
HUMAN ANATOMY AND PHYSIOLOGY-I (BP101T)
- CO1: Understand anatomical terminology and body organization based on structure, functions and regulation of cells, tissues, and membranes, applying this knowledge in health-related contexts.
- CO2: Classify skeletal system and joints based on their structure, and functions, applying this knowledge to explain their roles in protection, movement, and support.
- CO3: Describe body fluids and blood based on the composition, functions, and their regulation, applying this knowledge in role of maintaining homeostasis.
- CO4: Memorize organization of nervous system based on their functions, and neural communication, applying this knowledge to explore coordination, reflexes, and neurological health.
- CO5: Discuss cardiovascular system based on their structure and functions, applying this knowledge to evaluate cardiac health.
PHARMACEUTICAL ANALYSIS-I (BP102T)
- CO1: Understand the use of various pharmaceutical analytical methods and related terms in analysis of drugs and pharmaceutical excipients
- CO2: Apply aqueous and non aqueous titration in analysis of drugs and excipients
- CO3: Apply precipitation and complexometric titration in analysis of drugs and excipients
- CO4: Apply redox titration in analysis of drugs and excipients
- CO5: Apply electrochemical methods of analysis in analysis of drugs and excipients
PHARMACEUTICS-I (BP103T)
- CO1: Explain career opportunities in pharmacy, different types of dosage and dose calculation based on age, body weight and body surface area of the patient.
- CO2: Understand powder and liquid dosage forms, excipients used in liquid dosage forms and solubility enhancement techniques based on nature of dosage forms.
- CO3: Remember monophasic and biphasic liquid formulations along with their preparation methods based on nature of liquid dosage forms.
- CO4: Define and understand suppository, displacement value and pharmaceutical incompatibilities based on physical, chemical and therapeutic properties of the drug.
- CO5: Discuss semisolid dosage forms, its preparation methods and evaluation parameters based on type of semisolid dosage forms.
PHARMACEUTICAL INORGANIC CHEMISTRY (BP104T)
- CO1: Discuss the history of pharmacopoeia, monographs, impurities determination of inorganic compounds and pharmaceuticals through the understanding of pharmacopoeia editions and principles of limit test.
- CO2: Apply the concepts of acid, base, buffers, electrolytes and dental products for their use in pharmaceutical preparations.
- CO3: Express the properties, assay and medicinal uses of inorganic compounds based on the knowledge of Gastrointestinal tract and their mechanism of action.
- CO4: Illustrate the mechanism, method of preparation, properties, assay and medicinal importance of inorganic compounds based on their categories of expectorants, emetics, hematinics, poison antidote and astringents.
- CO5: Describe radioisotopes based on the understanding of different radiations along with their properties, measurement techniques, storage conditions, precautions and pharmaceutical applications.
COMMUNICATION SKILLS (BP105T)
- CO1: Discuss the basic concepts/ knowledge of the Communication process, its types, Barriers to communication and Perspectives in communication.
- CO2: Define the Elements of communication: Tone, body language, gesture, communication styles, Verbal and Non-verbal mode of communication
- CO3: Use Basic Listening skills: active listening, listening in difficult situations, Written communication: shades of meaning, complexity, Audience factor, organization of the message
- CO4: Operate the interview skills, do's and don'ts of an interview, and presentation skills: planning and structuring, delivery, and presentation techniques.
- CO5: Discuss about the Group Discussion and its aspects: role of communication skills in GD and Do's and Don'ts of GD
REMEDIAL BIOLOGY (BP106RBT)
- CO1: Students will be able to learn about basic concept/ Knowledge of animal cell, Aminal Tissue, cell division and cell organelles'
- CO2: Students will be able to learn about basic concept/ Knowledge of plant respiration, plant growth and development, plant and mineral nutrition, photosynthesis
- CO3: Students will be able to learn about classifications & salient feature of five kingdoms of life Anatomy and Physiology human, anatomy and physiology of plant
- CO4: Students will be able to learn about circulatory, digestive, respiratory and excreatory system of human
- CO5: Students will be able to learn about Morphology of plant, Root, Stem, Leaf and its modification
REMEDIAL MATHEMATICS (BP106RMT)
- CO1: Students will be able to learn about basic skills and extend their knowledge as they prepare for more advanced work.
- CO2: Students will be able to learn about mathematical concepts and principles to perform computations for Pharmaceutical Sciences.
- CO3: Students will be able to learn about classifications & salient feature of basic mathematics such as Identifying numbers, arrange numbers into arrays, to find solution of pharmacokinetics equations, etc.
- CO4: Student shall be able to Know Trignometry, Analytical geometry, Matrices, Determinant, Integration, Differential equation, Laplace transform and their applications.
- CO5: Students will be able to learn to solve the problems of different types by applying theory and appreciate the important applications of mathematics in pharmacy.
MEDICAL TERMINOLOGY (PMT113)
- CO1: Correctly identify the roles of the four types of word parts in forming medical terms.
- CO2: Identify unfamiliar medical terms using their knowledge of word parts
- CO3: Use basic prefixes, suffixes, and combining forms to build medical terms
- CO4: Explain the rules for proper pronunciation and spelling
- CO5: Relate the terminology to the names, locations, and functions of the major organs of the body systems
PRACTICAL
PRACTICAL HUMAN ANATOMY AND PHYSIOLOGY-I (BP107P)
- CO1: To demonstrate the permanent slide of various tissues of the human body.
- CO2: Identification of skeletal framework with reference to axial and appendicular systems.
- CO3: To perform the hematological sample analysis for interpretation of the result.
- CO4: Determination of normal physiological parameters of the human body in context to pulse rate, heart rate, and blood pressure.
PHARMACEUTICAL ANALYSIS-I (BP108P)
- CO1: Understand the knowledge on preparatory pharmacy and professional way of evaluating various conventional drugs, raw materials and formulations.
- CO2: Explain the theoretical basis of commonly used statistical methods & correctly analyze & interpret the results of statistical data from surveys, experiments & observational studies.
- CO3: Illustrate sources of errors in analytical techniques, methods to minimize them.
- CO4: Describe the various titrimetric and electrochemical methods of analysis and their application in quality control of pharmaceuticals
- CO5: Describe gravimetry and limit tests-principles and applications.
PHARMACEUTICS-I (BP109P)
- CO1: Explain monophasic liquid formulation based upon their preparation methods.
- CO2: Describe biphasic liquid formulation based upon knowledge of their preparation and stability issues.
- CO3: Prepare powder and granules formulation using the knowledge of formulation composition.
- CO4: Estimate suppositories formulation on the basis of their calculation.
- CO5: Prepare semi-solid dosage forms using displacement value and its calculation.
PHARMACEUTICAL INORGANIC CHEMISTRY (BP110P)
- CO1: Judge the impurities present in the given samples based on the knowledge about the principles, techniques of performing limit test.
- CO2: Examine the given inorganic compounds based on the physical properties, chemical reactions and organoleptic properties of the given inorganic compounds
- CO3: Examine the swelling power, neutralizing capacity and potassium iodate and iodine presence in bentonite, aluminum hydroxide gel and potassium iodide respectively by following the procedure and principles for the same.
- CO4: Synthesis of boric acid, potash alum and ferrous sulphate based on the knowledge of their physical properties and medicinal uses.
COMMUNICATION SKILLS (BP111P)
- CO1: Identifying the importance of interactive skills like meeting people, making friends, etc.
- CO2: Understanding the usage of basic grammar like pronunciations, nouns, etc.
- CO3: Define Direct and Indirect Speech, Figures of Speech, Effective Communication, Writing Skills, and presentation skills.
REMEDIAL BIOLOGY (BP112RBP)
- CO1: Apply techniques for section cutting, mounting, and staining plant tissues
- CO2: Demonstrate the proper use and functions of a microscope for examining biological specimens
- CO3: Evaluate different tissues, blood groups, blood pressure, and tidal volume using appropriate techniques.
- CO4: Evaluate the quality and effectiveness of prepared permanent slides for microscopic analysis
- CO5: Identify cells and their inclusions, stem, root, and leaf structures, the anatomy of a frog, and bones.
Year/Sem.: I / II
HUMAN ANATOMY AND PHYSIOLOGY-II (BP201T)
- CO1: Given the anatomy and physiology of a neuron, demonstrate the anatomical and functional principles to categorize different components of the CNS and PNS and their roles in the body.
- CO2: Execute knowledge of the digestive system to predict the digestion, absorption of nutrient and abnormalities on digestive processes.
- CO3: Demonstrate the knowledge of the respiratory and urinary system to predict the potential effects of functional irregularities.
- CO4: Interpret the structure and functions of endocrine glands to analyse the hormonal regulation of physiological processes and homeostasis.
- CO5: Explain the physiological roles of the male and female reproductive systems in gamete production, hormone secretion, and sexual reproduction.
PHARMACEUTICAL ORGANIC CHEMISTRY-I (BP202T)
- CO1: Demonstrate the ability to assign classification, nomenclature and structural isomerism to organic compounds based on the knowledge of classification, nomenclature and isomerism.
- CO2: Demonstrate the preparation and reactions of alkanes, alkenes and conjugated dienes based on their hybridization, stabilities, kinetics and order of reactivity
- CO3: Interpret the reactions, structures, qualitative test and uses of alkyl halides and alcohols based on their kinetics and order of reactivity.
- CO4: Demonstrate the synthetic reactions, qualitative test, structure and uses of carbonyl compounds based on their nucleophilic, electromeric mechanism and named reactions.
- CO5: Demonstrate the effect of substituents, qualitative test and uses of carboxylic acids and aliphatic amines based on their acidity and basicity respectively.
BIOCHEMISTRY (BP203T)
- CO1: Understand the relationship and biological significance of biomolecules using bioenergetics principles.
- CO2: Apply the knowledge of metabolism of carbohydrates in relation to their impact on physiology and related metabolic disorders.
- CO3: Apply the knowledge of metabolism of ketone bodies, fatty acids, amino acids and neurotransmitters in relation to their impact on physiology and related metabolic disorders.
- CO4: Apply the knowledge of genetics and metabolism of nuleeotides, DNA and RNA in relation to their impact on physiology and related disorders.
- CO5: Apply the knowledge of enzymes activity, kinetics and inhibition in relation to normal physiology, metabolism, therapeutics and diagnostic application
PATHOPHYSIOLOGY (BP204T)
- CO1: Apply the process of inflammation and repair along with pathophysiology of atherosclerosis based on the understanding of homeostasis, cellular injury, sclerosis and atheroma.
- CO2: Interpret the causes, development, and clinical features based on their understanding of pathophysiological mechanisms of following disease: hypertension, congestive heart failure, ischemic heart disease, asthma, chronic obstructive pulmonary disease and renal failure.
- CO3: Sketch the causes, development, and clinical features based on their understanding of pathophysiological mechanisms of related disease: hematological, endocrine, neurological, and gastrointestinal diseases.
- CO4: Express the causes, development, and clinical features based on their understanding of pathophysiological mechanisms of related disease: inflammatory diseases, liver conditions, bone and joint diseases, and cancer.
- CO5: Summarize the causes, development, and clinical features based on their understanding of pathophysiological mechanisms of following disease: meningitis, typhoid, leprosy, tuberculosis, urinary tract infections, and sexually transmitted diseases.
COMPUTER APPLICATIONS IN PHARMACY (BP205T)
- CO1: State the binary number, decimal number system, one complement and two complement method, data flow diagrams on their understanding of the number system, concept of information systems.
- CO2: Differentiate the HTML, XML, CSS, MYSQL, MS ACCESS various types of databases on their understanding of the web technologies, Programming languages and concept of basic database
- CO3: Classify the hospital and clinical pharmacy, drug information and patient monitoring system on their understanding of the various types of application of computers in pharmacy.
- CO4: Describe the Bioinformatics and databases and impact of Bioinformatics in Vaccine Discovery on their understanding of the Bioinformatics
- CO5: Identify the Chromatographic data analysis, LIMS, TIMS on their understanding of the Computers as data analysis in Preclinical development
ENVIRONMENTAL SCIENCES (BP206T)
- CO1: Students will be able to learn about basic concept of natural resource and environmental impacts of human activities on natural resource.
- CO2: Students will be able to learn about structure and functions of Ecosystem
- CO3: Students will be able to learn about types of environmental pollution and Its impact on human health and Environment
PRACTICAL
HUMAN ANATOMY AND PHYSIOLOGY-II (BP207P)
- CO1: Recognize the principle of homeostasis with special reference to feedback mechanism.
- CO2: Classify the nervous system with special reference to various anatomical and physiological neurological abnormalities.
- CO3: Demonstrate the anatomical and physiological framework of human body system (endocrine, digestive, respiratory, urinary, cardiovascular and reproductive, integumentary system) and special senses.
- CO4: Analyze the clinical significance of laboratory test for diagnosis of disorder
- CO5: Identify the permanent slide of vital organs and gonads.
PHARMACEUTICAL ORGANIC CHEMISTRY-I (BP208P)
- CO1: Investigate qualitative, solubility analysis, detection of elements of unknown organic compounds by following the safety procedure to set up glassware and apparatus to conduct experiments in organic chemistry.
- CO2: Analyze functional group of organic compounds based on their qualitative testing.
- CO3: Analyze the organic compounds systematically based on their reactions with the given reagents.
- CO4: Synthesize suitable solid derivatives from organic compounds, ingrained with the possible hazardous effect of overuse of organic products in daily life
- CO5: Predict the melting and boiling point of some organic compounds by judging their intermolecular forces of attractions.
BIOCHEMISTRY (BP209P)
- CO1: Understand the importance of metabolism of substrates and their bio regulation
- CO2: Will acquire chemistry and biological importance of biological macromolecules
- CO3: Acquainted with qualitative and quantitative estimation of the biological macromolecules
- CO4: Know, understand and apply the interpretation of data emanating from a Diagnostic Test Lab
- CO5: To know how physiological conditions and their variation influence the structures and relativities of biomolecules
COMPUTER APPLICATIONS IN PHARMACY (BP210P)
- CO1: Define the use of ms word, create and generate label, enter information, design questionnaire based on their understanding of the label wizard and uses of word processing package
- CO2: Apply the HTML toward the designing basic web page using notepad on the basic concept of HTML
- CO3: Analysis of the drug and its effect using online tool.
- CO4: Design the form to modify and Create the data base, patient information, drug information and invoice based on their understanding of MS access
- CO5: Implement to exporting Tables, Queries, Forms and Reports on their understanding of the web and xml page in MS access
Year/Sem.: II / III
PHARMACEUTICAL ORGANIC CHEMISTRY-II (BP301T)
- CO1: Analyze the derivation of benzene's structure using analytical, synthetic, and other evidences, including the application of orbital theory and resonance affecting its aromatic character and adherence to Huckel’s rule
- CO2: Evaluate the acidity of phenols and the basicity of aromatic amines on the basis of the effect of substituents on their aromatic ring, affecting acidity, basicity, reactivity, and aromaticity.
- CO3: Evaluate the quality of oils and fats by interpreting analytical constants derived from fatty acid reactions such as hydrolysis, hydrogenation, and saponification.
- CO4: Describe the synthesis, reactions, structures, and medicinal uses of Polynuclear hydrocarbons
- CO5: Analyze the stabilities of cycloalkanes using Baeyer’s strain theory, Coulson-Moffitt’s modification, and Sachse-Mohr’s theory to predict the stability and reactivity of cyclopropane and cyclobutane.
PHYSICAL PHARMACEUTICS-I (BP302T)
- CO1: Understand the mechanisms of solute solvent interactions, different factors affecting solubility of drugs, different law of binary solutions and miscibility of liquids based on the nature of the drug.
- CO2: Explain states and properties of matter, eutectic mixtures and various physicochemical properties of drug molecules based on the nature of the drug.
- CO3: Define and remember surface tension, how to measure surface and interfacial tension by different methods, surfactants and HLB scale based on nature of surfactants.
- CO4: Describe complexation and protein binding, and how protein binding effect on drug action based on nature of protein binding.
- CO5: Discuss buffer isotonic solutions, purpose behind maintaining the isotonicity of drug solution based on type of the solutions.
PHARMACEUTICAL MICROBIOLOGY (BP303T)
- CO1: Recall and outline the basic characteristics, structures, and functions, Assess and analyze the methods of identification, cultivation and preservation of various microorganisms.
- CO2: Explain the underlying principles of different sterilization methods used to maintain aseptic conditions in pharmaceutical manufacturing environments. Evaluation and Use of Staining and sterilization methods.
- CO3: To understand about disinfectants, and their evaluation, sterility testing methods of pharmaceutical products. Assess and analyze the consequences of microbial contamination in pharmaceutical products and production processes, considering factors such as product safety, efficacy, and regulatory compliance.
- CO4: Describe about aseptic area, sources of contamination, clean area classification and microbiological standardization methods of Pharmaceuticals. Use microbiological testing techniques to conduct quality control assessments of pharmaceutical products, interpreting results to ensure adherence to industry standards and regulatory requirements.
- CO5: Explain the microbial spoilage of pharmaceutical products, Preservation of pharmaceutical products. Develop innovative approaches and preventive strategies to minimize the risk of microbial contamination in pharmaceutical manufacturing environments, integrating knowledge of microbiological principles and industry best practices.
PHARMACEUTICAL ENGINEERING (BP304T)
- CO1: Explain the operations of pharmaceutical manufacturing based on the principles of size reduction, size separation and fluid flow.
- CO2: Apply the strategies for distillation and evaporation based on the knowledge of heat processes.
- CO3: Illustrate the procedures during development of pharmaceutical dosage forms based on the knowledge of drying and mixing.
- CO4: Solve the issues related to the fabrication of pharmaceutical dosage forms based on the principles of filtration and centrifugation.
- CO5: Sketch the quality designing of pharmaceutical plants based on the knowledge of corrosion and material handling aspects
PRACTICAL
PHARMACEUTICAL ORGANIC CHEMISTRY-II (BP305P)
- CO1: Apply concepts of molar calculations to calculate percentage yield as per standard stoichiometric calculations.
- CO2: Apply simple purification techniques such as recrystallization and steam distillation to purify organic compounds and intermediates according to standard synthetic procedures and protocols.
- CO3: Evaluate the quality of fats and oil by determining various parameters like acid value, saponification value and iodine value as per pharmacopeia
- CO4: Apply the concepts of different reaction mechanisms to synthesize medicinally important compounds based on standard protocol.
- CO5: Analyze the final product and the reaction mechanism involved in the synthesis of organic compounds like substitution, addition, oxidation, reduction coupling and condensation reactions based on the concepts of effect of substituent on stability and reactivity of aromatic ring.
PHYSICAL PHARMACEUTICS-I (BP306P)
- CO1: Apply appropriate techniques to determine the solubility of a given drug sample
- CO2: Analyze the implications and significance of the partition coefficient in pharmaceuticals
- CO3: Examine the effects and significance of surface tension in pharmaceutical applications
- CO4: Explain the importance of surfactants and HLB and their role in the stabilization of dosage forms
- CO5: Describe the process of calculating the stability constant and donor-acceptor ratio of complexes
PHARMACEUTICAL MICROBIOLOGY (BP307P)
- CO1: Understand the use of different types of microscopes and laboratory apparatus in experimental microbiology.
- CO2: Understand and apply techniques such as the Hanging Drop method, simple staining, negative staining, and Gram staining for the identification of bacteria and the study of bacterial motility and staining characteristics in microbiological experiments.
- CO3: Understand and apply techniques for preparing nutrient broth and agar, performing autoclave sterilization, and conducting aseptic transfers in microbiological settings.
- CO4: Understand and apply techniques for performing inoculation of agar plates using the spread plate method and isolation of bacteria from given cultures using the streaking plate method in microbiological experiments.
- CO5: Understand and apply techniques for performing sterility testing of pharmaceutical products and antibiotic susceptibility tests using the antibiotic disc (Kirby-Bauer) method in microbiological experiments.
PHARMACEUTICAL ENGINEERING (BP308P)
- CO1: Analyze the effects of different factors on rate of filtration and evaporation.
- CO2: Execute the process of size reduction and size distribution analysis.
- CO3: Determine the basic parameters of different heat processes.
- CO4: Demonstrate the working aspects of different pharmaceutical machineries.
- CO5: Evaluate the process of mixing and moisture content determination during pharmaceutical manufacturing.
Year/Sem.: II / IV
PHARMACEUTICAL ORGANIC CHEMISTRY-III (BP401T)
- CO1: Apply concepts of optical isomerism in resolution of racemic mixtures, reactions of chiral molecules and asymmetric synthesis of organic compounds.
- CO2: Use the concept of geometrical isomerism to synthesize isomers by stereospecific and stereoselective reactions
- CO3: Analyze the relative aromaticity, stability and reactivity of five membered heterocyclic rings in the reactions and synthesis of heterocyclic compounds
- CO4: Relate the chemistry of six membered and fused ring heterocyclic compounds in the synthesis of medicinal compounds
- CO5: Implement reactions of synthetic significance to sketch synthetic route for organic compounds
MEDICINAL CHEMISTRY-I (BP402T)
- CO1: Describe the history and development of medicinal chemistry, influence of physicochemical properties on drug action, kinetics, drug metabolism based on the understanding of physicochemical properties and metabolism.
- CO2: Demonstrate the biosynthesis, catabolism and receptor interactions of cholinergic neurotransmitters based on understanding with chemical structure, drug’s therapeutic potential, structure activity relationship and synthesis of parasympathomimetic agents, cholinesterase inhibitors and cholinergic blocking agents.
- CO3: Demonstrate the biosynthesis catabolism and receptor interaction of adrenergic neurotransmitters based on understanding with chemical structure, drug’s therapeutic potential, structure activity relationship and synthesis of sympathomimetic agents and adrenergic blockers.
- CO4: Illustrate the drug’s therapeutic potential, structure activity relationship based on their understanding of the chemical structure of CNS acting drugs: sedatives and hypnotics, antipsychotics and anticonvulsants.
- CO5: Illustrate the drug’s therapeutic potential, structure activity relationship based on their understanding of the chemical structure of the drugs: general anesthetics, narcotic and non-narcotic analgesic and anti-inflammatory agents.
PHYSICAL PHARMACEUTICS-II (BP403T)
- CO1: Understand the physicochemical properties of drug molecules in designing the dosage forms.
- CO2: Explain the role of surfactants, interfacial phenomenon and thermodynamics
- CO3: Describe the flow behavior of fluids and concept of complexation.
- CO4: Apply the principles of chemical kinetics & to use them for stability testing & determination of expiry dates of formulations.
- CO5: Analyze the physicochemical properties in the formulation development & evaluation of dosage forms.
PHARMACOLOGY-I (BP404T)
- CO1: Apply the general concepts of pharmacology to the process involved in drug pharmacokinetics.
- CO2: Understand the knowledge of receptor types, receptor theories, and signal transduction mechanisms to drug pharmacodynamics, drug discovery, clinical and preclinical evaluations of new drug, and Pharmacovigilance practices.
- CO3: Evaluate the pharmacological effects based on the understanding of drugs acting on Autonomic Nervous System, local anesthetics, myasthenia gravis, and glaucoma.
- CO4: Explain the pharmacological effects based on the understanding of drugs acting on CNS like- sedatives, hypnotics, anticonvulsants, general anesthetics, alcohol, and disulfiram.
- CO5: Discuss the pharmacological effects based on the understanding of drugs acting on CNS, such as antipsychotics, antidepressants, antianxiety agents, hallucinogens, CNS stimulants, and opioids, and assess the therapeutic approaches for Parkinson's and Alzheimer's diseases.
PHARMACOGNOSY AND PHYTOCHEMISTRY-I (BP405T)
- CO1: Evaluate crude drugs on the basis of WHO guidelines with respect to its biological sources, macroscopy, microscopy, chemical constituents and uses.
- CO2: Describe the concepts of cultivation on basis of WHO guidelines, implicated for improvement of quality of medicinal plants and minimization of crop destruction
- CO3: Demonstrate the importance of Plant tissue culture techniques, based on understanding of basic requirements, growth and their maintenance, for augmented exploitation of natural resources.
- CO4: Explain the contribution of traditional systems of medicine, given the specific principles of each system, for improvement in health care.
- CO5: Identify the secondary metabolites on the basis of its structure, distribution, properties and tests for identification to understand its role in health care.
PRACTICAL
MEDICINAL CHEMISTRY-I (BP406P)
- CO1: Prepare 1,3-pyrazole, 1,3-oxazole, benzimidazole, benzotriazole, and 2,3-diphenyl quinoxaline.
- CO2: Prepare benzocaine, phenytoin, phenothiazine, and barbiturate by synthetic processes to achieve high-yield and pure drugs.
- CO3: Describe the purity and potency of chlorpromazine, phenobarbitone, atropine, ibuprofen, aspirin, and furosemide using appropriate assay methods.
- CO4: Demonstrate the partition coefficient of paracetamol and diclofenac, explaining the significance of the partition coefficient in drug design and the methodology used to measure it, with a focus on the shake-flask method.
PHYSICAL PHARMACEUTICS-II (BP407P)
- CO1: Understand the Methods for determining particle size distribution (sieving and microscopic), bulk density, true density, and porosity.
- CO2: Analyze the angle of repose of the given powder sample.
- CO3: Analyze the viscosity of liquids by Ostwald's viscometer and semi-solids by Brookfield viscometer.
- CO4: Understand the sedimentation volume with various suspending agents and varying concentrations of a single suspending agent.
- CO5: Analyze the reaction rate constants for first and second order reactions, and conducting accelerated stability studies and shelf life determination for aspirin.
PHARMACOLOGY-I (BP408P)
- CO1: Conceptual knowledge of experimental pharmacology basics
- CO2: Understand the CPCSEA guidelines for laboratory animal facility.
- CO3: Precise knowledge about commonly used instruments in pharmacological laboratory.
- CO4: Observe the effect of drugs on animals by simulated experiments by software’s and videos.
- CO5: To understand the different methods of local anesthetics.
PHARMACOGNOSY AND PHYTOCHEMISTRY-I (BP409P)
- CO1: Understand the basic concept of microscope for microscopic evaluation of crude drugs.
- CO2: Identify crude drugs on the basis of their chemical testing.
- CO3: Identify crude drug adulterants on the basis of physicochemical testing.
- CO4: Identify characteristics of crude drugs through various physicochemical testing.
- CO5: Recognize crude drugs based on their macroscopic and microscopic characteristics.
Year/Sem.: III / V
MEDICINAL CHEMISTRY-II (BP501T)
- CO1: Evaluate the pharmacodynamics, pharmacokinetics, stability, synthesis, and therapeutic potential by using knowledge of the chemical structure and Structure-Activity Relationships (SAR) of drugs that are categorized as antiallergic, antihistamine, antiulcer, and antineoplastic agents.
- CO2: Based on the comprehension of the drugs chemical structure and Structure-Activity Relationships (SAR), Judge the therapeutic potential, structure activity relationship, pharmacodynamics, pharmacokinetics, stability, and synthesis of the following categories: antianginal, diuretics, and antihypertensives.
- CO3: Based on understanding of the chemical structures and Structure-Activity Relationships (SAR) of the following pharmacological classes—congestive heart failure, antiarrhythmics, and antihyperlipidemics—Defend their therapeutic potential, pharmacodynamics, pharmacokinetics, stability, and synthesis.
- CO4: Appraise the therapeutic potential, structure-activity relationship, pharmacology, stability, and synthesis of drugs by utilising knowledge of the chemical structures of drugs that affect the thyroid and, sex hormones.
- CO5: Evaluate the drugs therapeutic potential, structure activity relationship, pharmacodynamics, pharmacokinetics, stability and synthesis in the following categories based on their understanding of the chemical structure of the drugs: antidiabetic and local anesthetics
INDUSTRIAL PHARMACY-I (BP502T)
- CO1: Execute the knowledge of physicochemical properties of drugs (Pre-formulations) as a tool in the optimization of solid and liquid dosage forms.
- CO2: Describe the formulation of tablets, capsules and liquid orals using established procedures and technology.
- CO3: Understand the various considerations in development of capsules and pellets on the basis of their manufacturing techniques.
- CO4: Analyze parenteral and ophthalmic dosage forms based on their types.
- CO5: Explain formulation methods of cosmetics products and aerosols with appropriate packaging materials based on their applications.
PHARMACOLOGY-II (BP503T)
- CO1: Judge the therapeutic potential, pharmacodynamic and pharmacokinetic of drugs used in the management of congestive heart failure, hypertension, angina, arrhythmia and hyperlipidemia based on their knowledge of haemodynamic and electrophysiology of heart.
- CO2: Appraise the application of blood forming agents and their role in treatment of cardiovascular disorders, further able to analyse the importance of diuretics in cardiovascular diseases based on their knowledge of blood disorders its pathophysiology and pharmacology of drugs used in the management of these disorders.
- CO3: Distinguish the pharmacology of anti-histaminic, anti-serotonrotoniergic, NSAIDs, angiotensin, bradykinin, substance P, anti-gout anti-rheumatic drugs after having the knowledge of physiology of histamine, serotonin, prostaglandin and other autocoids.
- CO4: Analyse the treatment and management of endocrine disorders such as gigantism, dwarfism, hypo and hyperthyroidism, diabetes and disorders of adrenal glands based on their knowledge of pathophysiology of these disorders and pharmacology of drugs used in management of these disorders.
- CO5: Compare the androgens, anabolic steroids, estrogens, progesterone, oral contraceptives and drugs acting on the uterus based on the knowledge of role of male and female sex hormones and pharmacology of drugs of these categories. Perform the bioassay of insulin, oxytocin, vasopressin, ACTH, d-tubocurarine, digitalis, histamine after having the basic knowledge of these hormones and drugs.
PHARMACOGNOSY AND PHYTOCHEMISTRY-II (BP504T)
- CO1: Judge the production and significance of plant secondary metabolites through various biosynthetic pathways based on radioactive isotope studies.
- CO2: Investigate the different plants' secondary metabolites chemistry, bio-sources, therapeutic uses, and commercial applications of the following categories based on their chemical classes of secondary metabolites: Alkaloids, Phenylpropanoids and Flavonoids, Lignans, Steroids, Cardiac Glycosides & Triterpenoids, Volatile oils, Tannins, Resins, Glycosides and Iridoids.
- CO3: Develop the skill in extraction, isolation, analysis, confirmation, and estimation of phytoconstituents of the following categories based on chromatography and spectroscopic methods: Terpenoids, Glycosides, Alkaloids and Resins.
- CO4: Apply the industrial production and estimation methods of therapeutically important drugs based on herbal phytoconstituents.
- CO5: Develop competency in the modern methods for extraction and use of the latest techniques for analysis formulations based on herbal phytoconstituents.
PHARMACEUTICAL JURISPRUDENCE (BP505T)
- CO1: Understand the regulation licensing penalties based on testing and examination of new drug.
- CO2: Remember the various schedules for drug sale regulation on the basis of licensing authorities along with offence and penalities.
- CO3: Discuss the various pharmacy Acts based on their goals, descriptions, licencing, export, manufacture, regulatory bodies, controls, consultation committees, and fines.
- CO4: Analyze the cruelty to animal act and recognize the drug and magic remedies act on the basis of ethical guidelines and price control.
- CO5: Review the drug committees, Code of Pharmaceutical Ethics, Medical Termination of Pregnancy Act, Right to Information Act, and an introduction to Intellectual Property Rights (IPR) on the basis of pharmaceutical legislations.
PRACTICAL
INDUSTRIAL PHARMACY-I (BP506P)
- CO1: Understand the preparation and evaluation of tablet on the basis of preformulation studies of various tablets.
- CO2: Understand the preparation and evaluation of tetracycline capsules.
- CO3: Understand the prepration of injection on the basis of evaluation of various glass containers.
- CO4: Understand the prepration of various topical preprations.
- CO5: Understand the prepration of various opthalmic preprations.
PHARMACOLOGY-II (BP507P)
- CO1: To understand the basic principle of bioassay and types of bioassay.
- CO2: To demonstrate isolation of different organs/tissues from the laboratory animals by In Silico.
- CO3: To understand the effect of different drugs on the concentration response curves.
- CO4: To demonstrate the various receptor actions using isolated tissue preparation
- CO5: To understand the application of pharmacological knowledge in the prevention and treatment of various disease.
PHARMACOGNOSY AND PHYTOCHEMISTRY-II (BP508P)
- CO1: Develop the competency in extraction and isolation techniques of the phytoconstituents.
- CO2: Develop competency in the assessment of different phytoconstituents.
- CO3: Develop the skill in the estimation of different phytoconstituents by chromatography methods.
- CO4: Develop the skill in the isolation techniques of volatile oils.
- CO5: Estimate the different sugars of herbal drugs by paper chromatography.
Year/Sem.: III / VI
MEDICINAL CHEMISTRY-III (BP601T)
- CO1: Evaluate the pharmacodynamics, pharmacokinetics, stability, therapeutic potential, and synthesis of the Beta-lactams, monobactams, lactamase inhibitors, and aminoglycoside antibiotic classes using knowledge of chemical structure and Structure-Activity Relations
- CO2: Evaluate the pharmacodynamics, pharmacokinetics, stability, therapeutic potential, and synthesis of the tetracyclines, macrolide, polyenes and miscellaneous antibiotic classes using knowledge of chemical structure and Structure-Activity Relationships (SAR) and appraise the basic concept and application of prodrug design.
- CO3: Judge the drug’s therapeutic potential, structure activity relationship, pharmacodynamics, pharmacokinetics, stability and synthesis in the following categories based on their understanding of the chemical structure of the drugs: antitubercular, urinary tract anti-infectives and antivirals.
- CO4: Based on understanding of the chemical structures and Structure-Activity Relationships (SAR) of the following pharmacological classes— antifungal, antiprotozoal and anthelmintic—Defend their therapeutic potential, pharmacodynamics, pharmacokinetics, stability,
- CO5: Apply different drug design approaches and technique towards the drug development based on the basic concept of drug design.
PHARMACOLOGY-III (BP602T)
- CO1: Analyse the pharmacodynamic and pharmacokinetic properties of drugs based on the understanding of pathophysiology and drugs used in the diseases of the following system: Respiratory and gastrointestinal system.
- CO2: Discuss the therapeutic potential, drug interaction and toxicity management of drugs based on understanding of pharmacokinetic and pharmacodynamic of drugs in the following categories: Sulfonamides, cotrimoxazole, Penicillins, cephalosporins, chloramphenicol, macrolides, quinolones and fluoroquinolones, tetracycline and aminoglycoside..
- CO3: Describe the management of tuberculosis, leprosy, fungal and viral diseases, helminthiasis, malaria and amoebiasis after having the knowledge of aetiology and pharmacology of drugs used in these diseases.
- CO4: Evaluate the pharmacology and therapeutic strategies for UTIs, STDs, malignancies and immunocompromised patients after having the knowledge of aetiology, pathophysiology and pharmacology of drugs used in these ailments such as immunosuppressant, immunostimulants, protein drugs, monoclonal antibodies and biosimilars.
- CO5: Explain types of toxicity and their management including genotoxicity, carcinogenicity, teratogenicity, mutagenicity, teratogenicity, mutagenicity and the principles of treating poisoning based on their knowledge of gene structure and function and type and mechanism of poison. Illustrate the rhythm, cyles and biological clocks and their significance in chronotherapy based on their knowledge of time of disease exacerbation and its relation with particular time (morning, afternoon, evening, night).
HERBAL DRUG TECHNOLOGY (BP603T)
- CO1: Evaluate the herbal raw material as a source of crude drugs for the preparation of herbal medicine based on Good agricultural practices in the cultivation of medicinal plants including Organic farming.
- CO2: Judge the Nutraceuticals, Herbal-Drug, and Herb-Food Interactions, in the treatment of various diseases and Herbal-Drug and Herb-Food Interactions, based on the health benefits of Nutraceuticals in ailments like Diabetes, CVS diseases, Cancer, Irritable bowel syndrome, and various Gastrointestinal diseases.
- CO3: Investigate the herbal raw material for the preparation of herbal cosmetics and herbal nano-formulations based on protective and antioxidant effects for skin and, hair care.
- CO4: Eestimate the herbal drug preparations as per the WHO and ICH guidelines and knowledge about the IPR, patenting aspects, and regulatory issues for the assessment of traditional drugs and natural products.
- CO5: Develop competency in the testing and manufacturing practices of herbal drugs in Indian systems of medicine.
BIOPHARMACEUTICS AND PHARMACOKINETICS (BP604T)
- CO1: Understand the mechanisms of drug absorption through the GIT and non-per oral extravascular routes based on the nature of the drug.
- CO2: Explain metabolic pathways, factors affecting renal excretion of drugs and different terms of bioavailability based on physicochemical properties of the drug.
- CO3: Apply pharmacokinetic principles, including compartment and non-compartment models, physiological models, and one-compartment open models for various administration routes, as well as calculate and interpret key pharmacokinetic parameters based on route of administrations.
- CO4: Apply the principles of the two-compartment open model, calculate loading and maintenance doses based on drug properties.
- CO5: Analyze the concept of non-linear pharmacokinetics and explain the factors causing non-linearity and use Michaelis-menton equation to estimate parameters based on pharmacokinetics parameters of the drug.
PHARMACEUTICAL BIOTECHNOLOGY (BP605T)
- CO1: Recall the basic principles and applications of biotechnology in the pharmaceutical field. Describe the role of enzymes in biotechnological processes and their pharmaceutical relevance.
- CO2: Manufacturing processes and biotechnological methods.
- CO3: Develop new pharmaceutical products such as vaccines and Monoclonal antibodies.
- CO4: Explain the importance of various immunological techniques i.e. Microbial genetics, Microbial biotransformation and Mutation. Analyze social implications of biotechnological advances in pharmaceuticals.
- CO5: Organic acids, antibiotics etc. Evaluate the efficacy and safety of Blood products.
QUALITY ASSURANCE (BP606T)
- CO1: Understand the scope of quality management, QbD, ICH guidelines, ISO and NABL accreditation based on their principles and processes.
- CO2: Describe the concepts of maintenance of organization and personnel responsibilities on the basis of pharmaceutical industrial flow parameters.
- CO3: Analyze the cGMP aspects in the pharmaceutical industry on the basis of understanding operational parameters.
- CO4: Explain the basic concept of complaints, goods handling and recalling, waste disposal and documentation employing QA & QC reports.
- CO5: Analyze the significance of calibration, validation and qualification based on the concept of quality assurance.
PRACTICAL
MEDICINAL CHEMISTRY-III (BP607P)
- CO1: Understand the fundamental methodologies, instruments, and safety protocols essential for the synthesis and assay procedures of pharmacologically significant compounds.
- CO2: Apply the concepts of different reaction mechanism to synthesize and purify medicinally important compounds based on standard protocol.
- CO3: Evaluate the purity of drug based on different analytical techniques and assay procedures as per IP/BP and USP.
- CO4: Apply green chemistry principles to the synthesis of APIs and drug intermediates, employing techniques such as microwave-assisted, solvent-free synthesis in accordance with established green chemistry principles.
- CO5: Apply computational chemistry techniques to sketch chemical structures, reactions and to calculate the physicochemical properties of drug-like molecules.
PHARMACOLOGY-III (BP608P)
- CO1: Determine the dosage for pharmacological experiments and convert it to a human dose using established calculation methods.
- CO2: Evaluating drugs for their gastrointestinal efficacy, hypoglycemic effects, and anti-allergic properties, and correlating clinical and biochemical parameters with the disease.
- CO3: Capable of understanding OECD guidelines, interpreting acute toxicity and related studies for safety evaluation, and analyzing the pharmacokinetic profile of the given drug.
- CO4: Conduct pyrogen tests, interpret the results, and apply regulatory standards to ensure safety and compliance in pharmaceutical testing.
- CO5: Proficient of applying appropriate biostatistical methods for data interpretation and calculations.
HERBAL DRUG TECHNOLOGY (BP609P)
- CO1: Develop the skill to check out the phytoconstituents by preliminary phytochemical screening of crude drugs.
- CO2: Develop the competency in determination of alcohol content of Asava and Arista.
- CO3: Develop the competency in determination of Aldehyde, Phenol and alkaloids content in herbal drug formulations.
- CO4: Develop the skill to prepare and standardization of extract in herbal formulations as per Pharmacopoeial requirements
- CO5: Develop the skill to prepare and standardized herbal extract in cosmetic formulations like creams, lotions and shampoos.
Year/Sem.: IV / VII
INSTRUMENTAL METHODS OF ANALYSIS (BP701T)
- CO1: Examine the pharmaceutical substance by UV-Visible spectroscopy and Fluorimetry on the basis of the chemical structure of the pharmaceutical substance.
- CO2: Judge the IR spectroscopy, flame photometry, atomic absorption spectroscopy and nepheloturbidometry on the basis of the chemical structure of the pharmaceutical substance.
- CO3: Recognize the pharmaceutical substance by chromatography and electrophoresis on the basis of the chemical structure of the pharmaceutical substance.
- CO4: Investigate the principle, instrumentation and applications of gas chromatography and high performance liquid chromatography on the basis of the chemical structure of the pharmaceutical substance.
- CO5: Appraise the ion exchange chromatography, gel chromatography and affinity chromatography on the basis of the chemical structure of the pharmaceutical substance.
INDUSTRIAL PHARMACY-II (BP702T)
- CO1: Reframe pilot plant scale-up processes for pharmaceutical products, ensuring compliance with regulatory guidelines and effective documentation practices.
- CO2: Recommend the technology transfer processes in the pharmaceutical industry; including quality risk management, documentation, regulatory compliance, and commercialization, with a specific focus on WHO guidelines.
- CO3: Based on understanding of regulatory requirements for drug approval: Grade their preparation and submission of key documents such as IND and NDA applications, and manage clinical studies in compliance with FDA guidelines.
- CO4: Appraise the Total Quality Management, Quality by Design, Six Sigma, and compliance with ISO 9000 and ISO 14000 standards on the basis of knowledge of quality management systems in the pharmaceutical industry.
- CO5: Based on understanding of regulatory requirements, Conclude the approval procedures for new drugs in India and the roles and responsibilities of CDSCO and state licensing authorities.
PHARMACY PRACTICE (BP703T)
- CO1: Design the organizational structures and functions of hospitals, hospital pharmacies, and community pharmacies, as well as classify and manage adverse drug reactions effectively.
- CO2: Develop hospital and community pharmacy operations, including drug distribution systems, formularies, therapeutic drug monitoring, medication adherence strategies, patient medication history interviews, and management practices, ensuring optimal patient care and compliance with healthcare standards.
- CO3: Investigate pharmacy and therapeutic committee activities, drug information services, patient counseling techniques, education and training programs, and prescribed medication order communication skills to enhance patient care and healthcare delivery in a hospital setting.
- CO4: Implement budget plans, provide clinical pharmacy services, and manage over-the-counter (OTC) sales to optimize financial management, patient care, and pharmaceutical services.
- CO5: Develop effective strategies for drug store management and inventory control, conduct research on investigational drug use, and analyze interpretations of clinical laboratory tests to optimize pharmaceutical operations and improve patient care.
NOVEL DRUG DELIVERY SYSTEM (BP704T)
- CO1: Explain the criteria for selecting drugs and polymers for novel drug delivery systems, and describe various approaches for their development, formulation, and evaluation.
- CO2: Identify approaches, technologies, and drug carriers used to improve the selectivity, effectiveness, and/or safety of drug administration.
- CO3: Examine the benefits and limitations of Transdermal, Gastro-retentive, and Naso-pulmonary drug delivery systems.
- CO4: Evaluate the effectiveness of different Targeted Drug Delivery systems including liposomes, niosomes, nanoparticles, and monoclonal antibodies.
- CO5: Describe the different types of Ocular Drug Delivery Systems and Intrauterine Drug Delivery Systems including intra uterine devices (IUDs).
PRACTICAL
INSTRUMENTATION METHODS OF ANALYSIS (BP705P)
- CO1: Execute the qualitative and quantitative analysis of pharmaceutical substance by UV-Visible spectroscopy on the basis of the chemical structure of the pharmaceutical substance.
- CO2: Operate the fluorimetry for the analysis of pharmaceutical substance on the basis of the chemical structure of the pharmaceutical substance.
- CO3: Test the pharmaceutical substances by flame photometry and nepheloturbidometry on the basis of the chemical structure of the pharmaceutical substance.
- CO4: Implement the chromatographic separation of pharmaceutical sample on the basis of the chemical structure of the pharmaceutical substance.
- CO5: Demonstrate the advanced chromatographic technique on the basis of the chemical structure of the pharmaceutical substance.
PRACTICE SCHOOL (BP706PS)
- CO1: Understand the advanced instruments used and their applications in drug analysis.
- CO2: Understand the concepts and applications of alternative medicine.
- CO3: Learn to execute and utilize softwares of pharmaceutical importance.
- CO4: Understand the calibration of various analytical instruments.
- CO5: Know analysis of drugs using various analytical instruments.
Year/Sem.: IV / VIII
BIOSTATISTICS AND RESEARCH METHODOLOGY (BP801T)
- CO1: Describe the applications of biostatics and measure of central tendency, dispersion and correlation.
- CO2: Understand the regression analysis, probability theory and parametric tests.
- CO3: Apprehend the designing of methodology for research, observational and experimental studies.
- CO4: Know the concept of blocking, confounding and regression analysis and use of M.S. Excel, SPSS, R and MINITAB®, DoE (Design of experiment).
- CO5: Choose the appropriate design and analysis of experiments such as factorial design and response surface methodology.
SOCIAL AND PREVENTIVE PHARMACY (BP802T)
- CO1: Test the concept of health and disease on the basis of health education employing personal hygiene and health care.
- CO2: Evaluate the prevention and control of disease based on knowledge of preventive medicine.
- CO3: Grade the objectives of national health programs for control of diseases on the basis of various promotional health programme sc
- CO4: Appraise the national health intervention programme and role of WHO based on knowledge for control and prevention of diseases
- CO5: Analyse the concept of community health services on the basis of rural and urban community health mission
PHARMA MARKETING MANAGEMENT (BP803ET)
- CO1: Analyze the pharmaceutical marketing and market research on the basis of product and consumer profile.
- CO2: Apply product management in pharmaceutical marketing based on product positioning of new and existing pharmaceutical products.
- CO3: Execute different promotional technique for OTC products employing various platforms for product promotion
- CO4: Examine pharmaceutical marketing channels for sales management based upon physical distribution and professional sales representative.
- CO5: Interpret pharmaceutical product pricing on the basis of the concept of pricing designed by DPCO and NPPA guidelines for emerging pharmaceutical products.
PHARMACEUTICAL REGULATORY SCIENCE (BP804ET)
- CO1: Understand the concepts of innovator and generic drugs, drug development process.
- CO2: Know the regulatory guidance’s and guidelines for filing and approval process, preparation of dossiers and their submission to regulatory agencies in different countries.
- CO3: Know the regulatory authorities and agencies governing the manufacture and sale of pharmaceuticals and the submission of global documents in CTD/ eCTD, ASEAN formats.
- CO4: Understand the clinical trials requirements for approvals for conducting clinical trials, pharmacovigilance and process of monitoring in clinical trials.
- CO5: Knowledge of basic terminology, regulatory guidance’s, guidelines, laws and acts.
PHARMACOVIGILANCE (BP805ET)
- CO1: Understand the concept of pharmacovigilance with the reference to WHO international drug monitoring programme, Pharmacovigilance Program of India (PvPI), Detection and reporting, Methods in Causality assessment, Severity and seriousness assessment, Predictability and preventability assessment, Management of adverse drug reactions.
- CO2: Discuss the classification of drug and disease with respect to WHO adverse reaction.
- CO3: Appraise the Vaccine safety and its surveillance by basic understanding of adverse effects related to immunization.
- CO4: Describe the Pre clinical phase, Clinical phase, Post approval phase on the basis of ICH Guidelines for effective generation in safety data.
- CO5: Judge the genetics related ADR on the basis of Indian and global pharmacovigilance requirements with focus on pharmacokinetic parameters.
QUALITY CONTROL AND STANDARDIZATION OF HERBALS (BP806ET)
- CO1: Gain knowledge on biological source, active constituents and uses of crude drugs Understand the techniques of evaluation of crude drugs as per the WHO guidelines
- CO2: Understand the basic principles of cultivation, collection and storage of crude drugs Application of the crop improvement concepts involved in techniques for improvement of quality of medicinal plants
- CO3: Exploring the tissue culture technique in medicinal plants
- CO4: Appreciate the applications of Primary &Secondary metabolites of the plant and explore its medicinal importance based on its chemical class Understand the principles and application of different system of alternative medicine
- CO5: Explore novel medicinal agents from different sources of natural origin
COMPUTER AIDED DRUG DESIGN (BP807ET)
- CO1: Understand the process of Design and discovery of lead molecules
- CO2: Appreciate the role of drug design in drug discovery process
- CO3: Understand and apply the concept of QSAR and docking
- CO4: Apply various strategies to develop new drug like molecules
- CO5: Understand the designing of new drug molecules using molecular modeling software
- CO6: Appreciate importance of computational methods in drug design and discovery processes
CELL AND MOLECULAR BIOLOGY (BP808ET)
- CO1: Understanding the history of cell and molecular biology, cellular functioning and composition and chemical foundations of cell biology.
- CO2: Understanding about DNA and RNA and their functioning.
- CO3: Students able to Describe protein structure and function, Protein Synthesis
- CO4: Know the basic molecular genetic mechanisms.
- CO5: Summarize the Cell Cycle including Cell Signals, Receptors for Cell Signals, Signaling Pathways
COSMETIC SCIENCE (BP809ET)
- CO1: Gain information on key ingredients used in cosmetics and cosmeceuticals
- CO2: Understand key building blocks of cosmetics for various formulations
- CO3: Know the current technologies in the market
- CO4: Understand the scientific principles to develop cosmetics and cosmeceuticals with desired safety
- CO5: Know the various problems induced due to cosmetics
EXPERIMENTAL PHARMACOLOGY (BP810ET)
- CO1: Appreciate the knowledge gained on pre clinical evaluation of drugs and recent experimental techniques in the drug discovery and development.
- CO2: Understood the various laboratory animals and their maintenance as per the guidelines and also describe good laboratory practices in maintenance and handling of experimental animals.
- CO3: Appraised the regulations and ethical requirement for the usage of experimental animals.
- CO4: Learnt and describe the various pre clinical screening methods (in-vitro and in-vivo) involved in the drug discovery process.
- CO5: Correlate the pre clinical data to human’s clinical data.
ADVANCED INSTRUMENTATION TECHNIQUES (BP811ET)
- CO1: Investigate the pharmaceutical substances by NMR spectroscopy and mass spectrometry.
- CO2: Analyze the essentials of thermal methods of analysis and X ray diffraction methods.
- CO3: Apprehend the calibration and validation of analytical instruments.
- CO4: Recognize the fundamentals of radioimmunoassay and extraction techniques.
- CO5: Deal with the fundamentals of hyphenated techniques.
DIETARY SUPPLEMENTS & NUTRACEUTICALS (BP812ET)
- CO1: Assess the definitions and classifications of functional foods, nutraceuticals, and dietary supplements, their effectiveness in preventing or curing health issues and their sources, marker compounds, chemical nature, medicinal uses, and health benefits within the context of public health, maternal and child nutrition, ageing, and community nutrition education.
- CO2: Evaluate the occurrence, chemical nature, and medicinal benefits of various phytochemicals and functional foods, including carotenoids, sulfides, polyphenolics, flavonoids, prebiotics/probiotics, phytoestrogens, tocopherols, proteins, vitamins, minerals, and commonly consumed foods and beverages.
- CO3: Appraise the production and damaging effects of free radicals on cellular components and assess the role of dietary fibers and complex carbohydrates as functional food ingredients.
- CO4: Judge the role of free radicals in various diseases, including diabetes mellitus, inflammation, cancer, and atherosclerosis, and assess the effectiveness of endogenous and synthetic antioxidants and functional foods in chronic disease prevention.
- CO5: Create strategies to enhance the potential of nutraceuticals considering processing, storage, and environmental factors, and design regulatory compliance plans for food safety and quality standards, including FSSAI, FDA, FPO, MPO, AGMARK, HACCP, GMPs, and pharmacopoeial specifications.
PHARMACEUTICAL PRODUCT DEVELOPMENT (BP813ET)
- CO1: Explain pharmaceutical product development and regulations related to preformulation
- CO2: Classify the pharmaceutical excipients – semi solid dosage form
- CO3: Discuss about pharmaceutical excipients – solid dosage forms, liquid dosage forms and NDDS
- CO4: Explain the pharmaceutical product development by Optimization and quality by design (QbD) techniques
- CO5: Discuss about Pharmaceutical packaging and their regulatory considerations.
